Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
EMulate Therapeutics, Inc. logo — A modern approach to the treatment of cancer and other serio...

EMulate Therapeutics, Inc.

A modern approach to the treatment of cancer and other serious diseases.

Founded 2002 United States Seattle, United States 11 employees Biotechnology

General Information

Company Name EMulate Therapeutics, Inc.
Founded Year 2002
Location United States Seattle, United States +1
Employees 11
Industries Biotechnology
Social

Get notified when EMulate Therapeutics, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About EMulate Therapeutics, Inc.

EMulate Therapeutics is a pioneering biotechnology startup, established in 2002 and located in Seattle, WA. The company has developed an innovative technology, ulRFE®, which utilizes ultra-low radio frequency energy to regulate signaling and metabolic pathways on a molecular and genetic level. This groundbreaking approach, delivered through the EMulate Therapeutics Voyager device, aims to transform global disease treatment without the use of chemicals, radiation, or drugs. The company's primary focus is on revolutionizing the treatment of brain cancer, offering a more effective and less detrimental alternative to conventional therapies. Additionally, EMulate Therapeutics is conducting further research to explore applications in oncology and pain treatment. With its patented technology, the company has the potential to expand into various medical and non-medical fields, including veterinary medicine. EMulate Therapeutics is an exciting investment opportunity for venture capitalists seeking to support a company that is at the forefront of redefining disease treatment. As the company continues to advance its technology and expand its applications, it presents a promising prospect for investors looking to contribute to the future of healthcare.

Taxonomy: Therapeutic Devices, Cancer Treatment, Clinical-stage Therapeutics, ulRFE® Technology, Non-invasive Treatment, Brain Cancer, Oncology, Pain Treatment, Innovative Technology, Precision Medicine, Medical Innovation

No funding data available for EMulate Therapeutics, Inc. yet.

Get notified when EMulate Therapeutics, Inc. raises funding

EMulate Therapeutics, Inc. Alternatives & Competitors

EMulate Therapeutics, Inc. vs
Autem Therapeutics
Autem Therapeutics United States

EM-Powering Cancer Care

Series A
16 employees
Biotechnology, Health Care
EMulate Therapeutics, Inc. vs
Evanesc Therapeutics
Evanesc Therapeutics United States

Evanesc Therapeutics is revolutionizing the treatment of neurological diseases with their patented E...

3 employees
Health Care
EMulate Therapeutics, Inc. vs
Combat Medical Ltd
Combat Medical Ltd United Kingdom

Transforming Cancer Treatments Through World Leading Hyperthermic Technologies

26 employees

FAQ About EMulate Therapeutics, Inc.

A modern approach to the treatment of cancer and other serious diseases.
EMulate Therapeutics, Inc. was founded in 2002.
EMulate Therapeutics, Inc. is headquartered in Seattle, United States.
EMulate Therapeutics, Inc. operates in the following industries: Biotechnology.
EMulate Therapeutics, Inc. has approximately 11 employees.
Top alternatives and competitors to EMulate Therapeutics, Inc. include Autem Therapeutics, Evanesc Therapeutics, Combat Medical Ltd, PanTher Therapeutics, Vaxiion Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
EMulate Therapeutics, Inc. and Autem Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors EMulate Therapeutics, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy